Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barlow

Showing results (981-990 of 7,302) with videos related to

Pageof 731
Sort By:
Protoplasma|April 25, 2012
Strasburger's legacy to mitosis and cytokinesis and its relevance for the Cell TheoryFrantišek Baluška, Dieter Volkmann, Diedrik Menzel, et al.
Nurse Education Today|March 27, 2012
Supporting rural/remote primary health care placement experiences increases undergraduate nurse confidencePaul Bennett, Debra Jones, Janie Brown, et al.
International Journal of Sports Physical Therapy|September 10, 2011
Differences in change scores and the predictive validity of three commonly used measures following concussion in the middle school and high school aged populationMichael Barlow, Drew Schlabach, Jeffery Peiffer, et al.
The Laryngoscope|January 25, 2008
Longitudinal follow-up of adductor spasmodic dysphonia patients after botulinum toxin injection: quality of life resultsRandal C Paniello, Jamie Barlow, Jannie S Serna
Cancer Research|June 1, 1976
Uridine 5'-diphosphate-galactose:glycoprotein galactosyltransferase activity in the ovarian cancer patientM Bhattacharya, S K Chatterjee, J J Barlow
Ciba Foundation Symposium|January 1, 1984
Reichert's membrane as a model for studying the biosynthesis and assembly of basement membrane componentsB L Hogan, D P Barlow, M Kurkinen
Cancer Treatment Reports|January 1, 1981
Cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin (CHAD) as second-line chemotherapy for ovarian adenocarcinomaM S Piver, S Lele, J J Barlow
Bulletin of the New York Academy of Medicine|January 1, 1995
Injury prevention in an urban setting: challenges and successesD Laraque, B Barlow, M Durkin, et al.
Clinical Chemistry|May 1, 1993
Role of antibody valency in hapten-heterologous immunoassaysU Piran, D Silbert-Shostek, E H Barlow
Cognitive Behaviour Therapy|October 9, 2004
Non-specific encoding of threat in social phobia and panic disorderNina Heinrichs, Stefan G Hofmann, David H Barlow
Pageof 731

Showing results (981-990 of 7,302) with videos related to

Sort By:
Pageof 731
Protoplasma|April 25, 2012
Strasburger's legacy to mitosis and cytokinesis and its relevance for the Cell TheoryFrantišek Baluška, Dieter Volkmann, Diedrik Menzel, et al.
Nurse Education Today|March 27, 2012
Supporting rural/remote primary health care placement experiences increases undergraduate nurse confidencePaul Bennett, Debra Jones, Janie Brown, et al.
International Journal of Sports Physical Therapy|September 10, 2011
Differences in change scores and the predictive validity of three commonly used measures following concussion in the middle school and high school aged populationMichael Barlow, Drew Schlabach, Jeffery Peiffer, et al.
The Laryngoscope|January 25, 2008
Longitudinal follow-up of adductor spasmodic dysphonia patients after botulinum toxin injection: quality of life resultsRandal C Paniello, Jamie Barlow, Jannie S Serna
Cancer Research|June 1, 1976
Uridine 5'-diphosphate-galactose:glycoprotein galactosyltransferase activity in the ovarian cancer patientM Bhattacharya, S K Chatterjee, J J Barlow
Ciba Foundation Symposium|January 1, 1984
Reichert's membrane as a model for studying the biosynthesis and assembly of basement membrane componentsB L Hogan, D P Barlow, M Kurkinen
Cancer Treatment Reports|January 1, 1981
Cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin (CHAD) as second-line chemotherapy for ovarian adenocarcinomaM S Piver, S Lele, J J Barlow
Bulletin of the New York Academy of Medicine|January 1, 1995
Injury prevention in an urban setting: challenges and successesD Laraque, B Barlow, M Durkin, et al.
Clinical Chemistry|May 1, 1993
Role of antibody valency in hapten-heterologous immunoassaysU Piran, D Silbert-Shostek, E H Barlow
Cognitive Behaviour Therapy|October 9, 2004
Non-specific encoding of threat in social phobia and panic disorderNina Heinrichs, Stefan G Hofmann, David H Barlow
Pageof 731